The THRombolysis and STatins (THRaST) study

Neurology

Volumn 80, Issue 7, 2013, Pages 655-661

  Cappellari, Manuel ^a   Bovi, Paolo ^a   Moretto, Giuseppe ^a   Zini, Andrea ^b   Nencini, Patrizia ^c   Sessa, Maria ^d   Furlan, Mauro ^e   Pezzini, Alessandro ^f   Orlandi, Giovanni ^g   Paciaroni, Maurizio ^h   Tassinari, Tiziana ⁱ   Procaccianti, Gaetano ^j   Di Lazzaro, Vincenzo ^k   Bettoni, Luigi ^l   Gandolfo, Carlo ^m   Silvestrelli, Giorgio ⁿ   Rasura, Maurizia ^o   Martini, Giuseppe ^p   Melis, Maurizio ^q   Calloni, Maria Vittoria ^r   Chiodo Grandi, Fabio ^s   Beretta, Simone ^t   Guarino, Maria ^u   Altavista, Maria Concetta ^v   Marcheselli, Simona ^w   Galletti, Giampiero ^x   Adobbati, Laura ^y   Del Sette, Massimo ^o   Mancini, Armando ^z   Orrico, Daniele ^aa   Monaco, Serena ^ab   Cavallini, Anna ^ac   Sciolla, Rossella ^ad   Federico, Francesco ^ae   Scoditti, Umberto ^af   Brusaferri, Fabio ^j   Grassa, Claudio ^ag   Specchio, Luigi ^ah   Bongioanni, Maria Roberta ^ai   Sparaco, Marco ^aj   Zampolini, Mauro ^ak   Greco, Gabriele ^al   Colombo, Rinaldo ^am   Passarella, Bruno ^an   Adami, Alessandro ^ao   Consoli, Domenico ^ap   Toni, Danilo ^aq   more..

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

^b AUSL Modena   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d SAN RAFFAELE HOSPITAL   (Italy)

^e SC Neurologia   (Italy)

^f UNIVERSITY OF BRESCIA   (Italy)

^g UNIVERSITY HOSPITAL OF PISA   (Italy)

^h UNIVERSITY OF PERUGIA   (Italy)

ⁱ SANTA CORONA HOSPITAL   (Italy)

^j MAGGIORE HOSPITAL   (Italy)

^k UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^l CREMONA HOSPITAL   (Italy)

^m UNIVERSITY OF GENOA   (Italy)

ⁿ CARLO POMA HOSPITAL   (Italy)

^o SAPIENZA UNIVERSITY OF ROME   (Italy)

^p UNIVERSITY HOSPITAL OF SIENA   (Italy)

^q BROTZU HOSPITAL   (Italy)

^r Ospedale di Legnano   (Italy)

^s UNIVERSITY OF TRIESTE   (Italy)

^t SAN GERARDO HOSPITAL   (Italy)

^u UNIVERSITY OF BOLOGNA   (Italy)

^v SAN FILIPPO NERI HOSPITAL   (Italy)

^w HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^x MORGAGNI PIERANTONI HOSPITAL   (Italy)

^y ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^z SPIRITO SANTO HOSPITAL   (Italy)

^aa SANTA CHIARA HOSPITAL   (Italy)

^ab Ospedale Civile Di Vicenza   (Italy)

^ac C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^ad SAN LUIGI GONZAGA UNIVERSITY HOSPITAL   (Italy)

^ae POLICLINICO   (Italy)

^af UNIVERSITY HOSPITAL OF PARMA   (Italy)

^ag UOC Neurologia   (Italy)

^ah Azienda Ospedaliero Universitaria   (Italy)

^ai Azienda Sanitaria Locale Citta di Torino   (Italy)

^aj G RUMMO HOSPITAL   (Italy)

^ak Ospedale S Giovanni Battista   (Italy)

^al Ospedale Ramazzini   (Italy)

^am Ospedale di Lavagna   (Italy)

^an UO Neurologia Osp A Perrino   (Italy)

^ao SACRO CUORE DON CALABRIA HOSPITAL   (Italy)

^ap G Jazzolino Hospital   (Italy)

^aq SAPIENZA UNIVERSITY OF ROME   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; FEMALE; HUMAN; INTRACEREBRAL HEMORRHAGE TYPE 2; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NERVE DEGENERATION; NEUROLOGIC DETERIORATION; PRIORITY JOURNAL; RATING SCALE; COMPUTED TOMOGRAPHY SCANNER; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUROLOGIC EXAMINATION; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; TIME;

AGED; AGED, 80 AND OVER; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUROLOGIC EXAMINATION; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STROKE; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY SCANNERS, X-RAY COMPUTED;

MLCS; MLOWN;

EID: 84875861386     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318281cc83     Document Type: Article

References (24)

1. Prinz V, Endres M. Statins and stroke: prevention and beyond. Curr Opin Neurol 2011;24:75-80.
2. Endres M. Statins and stroke. J Cereb Blood Flow Metab 2005;25:1093-1110.
3. Lakhan SE, Bagchi S, Hofer M. Statins and clinical outcome of acute ischemic stroke: a systematic review. Int Arch Med 2010;3:22.
4. Sacco S, Toni D, Bignamini AA, et al. Effect of prior medical treatments on ischemic stroke severity and outcome. Funct Neurol 2011;26:133-139.
5. Biffi A, Devan WJ, Anderson CD, Cortellini L, Furie KL, Rosand J, et al. Statin treatment and functional outcome after ischemic stroke: case-control and meta-analysis. Stroke 2011;42:1314-1319.
6. Blanco M, Nombela F, Castellanos M, et al. Statin treatment withdrawal in ischemic stroke: a controlled randomized study. Neurology 2007;69:904-910.
7. Montaner J, Chacón P, Krupinski J, et al. Simvastatin in acute phase of ischemic stroke: a safety and efficacy pilot trial. Eur J Neurol 2008;15:82-90.
8. Lampl Y, Lorberboym M, Gilad R, et al. Early outcome of acute ischemic stroke in hyperlipidemic patients under atorvastatin versus simvastatin. Clin Neuropharmacol 2010;33:129-134.
9. Ní Chróinín D, Callaly EL, Duggan J, et al. Association between acute statin therapy, survival, and improved functional outcome after ischemic stroke: the North Dublin Population Stroke Study. Stroke 2011;42:1021-1029.
10. Goldstein LB, Amarenco P, Zivin J, et al. Statin treatment and stroke outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke 2009;40:3526-3531.
11. Martinez-Ramirez S, Delgado-Mederos R, Marín R, et al. Statin pretreatment may increase the risk of symptomatic intracranial haemorrhage in thrombolysis for ischemic stroke: results from a case-control study and a meta-analysis. J Neurol 2012;259:111-118.
12. Cordenier A, De Smedt A, Brouns R, et al. Pre-stroke use of statins on stroke outcome: a meta-analysis of observational studies. Acta Neurol Belg 2011;111:261-267.
13. Engelter ST, Soinne L, Ringleb P, et al. IV thrombolysis and statins. Neurology 2011;77:888-895.
14. Rocco A, Sykora M, Ringleb P, Diedler J. Impact of statin use and lipid profile on symptomatic intracerebral haemorrhage, outcome and mortality after intravenous thrombolysis in acute stroke. Cerebrovasc Dis 2012;33:362-368.
15. Wahlgren N, Ahmed N, Dávalos A, et al. Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet 2008;372:1303-1309.
16. Wahlgren N, Ahmed N, Dávalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007;369:275-282.
17. Kharitonova T, Mikulik R, Roine RO, Soinne L, Ahmed N, Wahlgren N; Safe Implementation of Thrombolysis in Stroke Investigators. Association of early National Institutes of Health Stroke Scale improvement with vessel recanalization and functional outcome after intravenous thrombolysis in ischemic stroke. Stroke 2011;42:1638-1643.
18. Saposnik G, Di Legge S, Webster F, Hachinski V. Predictors of major neurologic improvement after thrombolysis in acute stroke. Neurology 2005;65:1169-1174.
19. Delgado MG, Michel P, Naves M, et al. Early profiles of clinical evolution after intravenous thrombolysis in an un-selected stroke population. J Neurol Neurosurg Psychiatry 2010;81:282-285.
20. Cappellari M, Deluca C, Tinazzi M, et al. Does statin in the acute phase of ischemic stroke improve outcome after intravenous thrombolysis? A retrospective study. J Neurol Sci 2011;308:128-134.
21. Restrepo L, Bang OY, Ovbiagele B, et al. Impact of hyperlipidemia and statins on ischemic stroke outcomes after intra-arterial fibrinolysis and percutaneous mechanical embolectomy. Cerebrovasc Dis 2009;28:384-390.
22. Ntaios G, Lambrou D, Michel P. Blood pressure change and outcome in acute ischemic stroke: the impact of baseline values, previous hypertensive disease and previous antihyper-tensive treatment. J Hypertens 2011;29:1583-1589.
23. Zhang L, Chopp M, Jia L, Cui Y, Lu M, Zhang ZG. Atorvastatin extends the therapeutic window for tPA to 6 h after the onset of embolic stroke in rats. J Cereb Blood Flow Metab 2009;29:1816-1824.
24. Chen J, Zhang ZG, Li Y, et al. Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann Neurol 2003;53:743-751.